SEC Filings | Celldex Therapeutics

Form	Description	Filing date	View
SC 13G/A	An amendment to the SC 13G filing	Jan 29, 2015	View HTML 0001086364-15-001071.pdf 0001086364-15-001071.rtf
3	Initial filing by director officer or owner of more than ten percent.	Dec 19, 2014	View HTML 0000905718-14-000813.pdf 0000905718-14-000813.rtf 0000905718-14-000813.xls
4	Statement of changes in beneficial ownership of securities	Dec 19, 2014	View HTML 0000905718-14-000815.pdf 0000905718-14-000815.rtf 0000905718-14-000815.xls
8-K	Report of unscheduled material events or corporate event	Dec 18, 2014	View HTML 0001171843-14-005945.pdf 0001171843-14-005945.rtf 0001171843-14-005945.xls
CT ORDER	CT ORDER	Dec 17, 2014	View HTML 9999999997-14-015962.pdf
8-K	Report of unscheduled material events or corporate event	Nov 6, 2014	View HTML 0001104659-14-077686.pdf 0001104659-14-077686.rtf 0001104659-14-077686.xls
424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	Nov 6, 2014	View HTML 0001047469-14-008918.pdf 0001047469-14-008918.rtf 0001047469-14-008918.xls
10-Q	Quarterly report which provides a continuing view of a company's financial position	Nov 5, 2014	View HTML 0001104659-14-076822.pdf 0001104659-14-076822.rtf 0001104659-14-076822.xls EX-101.INS - XBRL INSTANCE DOCUMENT
8-K	Report of unscheduled material events or corporate event	Nov 4, 2014	View HTML 0001171843-14-005224.pdf 0001171843-14-005224.rtf 0001171843-14-005224.xls
D		Oct 24, 2014	View HTML 0001104659-14-073690.pdf 0001104659-14-073690.rtf 0001104659-14-073690.xls

Data provided by Kaleidoscope.